Investments

Clinical Candidates

Over ten GHIT development partnerships have conducted clinical programs worldwide.
Please see each program to know more details.

    • Malaria / Drug

      SJ733
        • Development Stage: Phase IIb Clinical Trial
        • Country: Peru
      Details
    • Malaria / Drug

      ALAQ-FDC
        • Development Stage: Phase III Clinical Trial, Registration
        • Country: Rwanda, Uganda, Angola, Nigeria, Thailand
      Details
    • Malaria / Vaccine

      AnAPN1
        • Development Stage: Phase I Clinical Trial
        • Country: Gabon (Planned)
      Details
    • Mycetoma / Drug

      Fosravuconazole
        • Development Stage: Under Regulatory Submission Preparation
        • Country: Sudan
      © Purushottam Diwakar-DNDi
      Details
    • Cutaneous leishmaniasis / Drug

      CpG-D35
        • Development Stage: Phase I Clinical Trial
        • Country: United Kingdom, Colombia
      © Sydelle Willow Smith-DNDi
      Details
    • Lymphatic filariasis, Onchocerciasis / Drug

      AWZ1066S
        • Development Stage: Phase I Clinical Trial
        • Country: United Kingdom, Cameroon (planned)
      Photo credit: Kate Dodd
      Details
    • Leprosy / Vaccine

      LepVax
        • Development Stage: Phase I Clinical Trial
        • Country: Brazil
      Details
    • Buruli Ulcer / Diagnostics

      BU-MYCOLAC
        • Development Stage: Product Development
        • Country: Cameroon, Ivory Coast
      Photo credit: FIND
      Details
    • Leishmaniasis / Diagnostics

      Leishmania Skin Test (LST)
        • Development Stage: Product Development
        • Country: India and Africa (Planned)
      Details
    • Schistosomiasis / Diagnostics

      SCH CAA RDT
        • Development Stage: Product Development
        • Country: Kenya, Philippines
      Details
    • Schistosomiasis / Pediatric Drug

      Arpraziquantel
        • Development Stage: Registration, Access
        • Country: Ivory Coast, Kenya, Uganda and other endemic countries.
      Photo credit: SCI Foundation/Uganda
      Details